Stem cells grown on scaffold mimic hip joint cartilage

NIH | AUGUST 14, 2016

A team from Washington University School of Medicine in St. Louis, previously engineered a scaffold to guide stem cells into cartilage-producing cells. The group set out to build on this work by incorporating a gene transfer approach to induce cells to produce an anti-inflammatory compound to prevent further joint degradation.

Stem cells (stained green) grew throughout the pores of the scaffold (stained red). Image credit: Guikak lab, Washington University

A layer of smooth cartilage lines the ends of the bones in many joints in the body. The cartilage has special properties that enable it to absorb energy, bear weight, and lubricate the joints so they can function seamlessly. In osteoarthritis, this cartilage breaks and wears away. Bones under the cartilage may then rub together, causing pain, swelling, stiffness, and disability.

Treatments include exercise, medications to control pain, and surgery to reposition or resurface the joint or to replace it with an artificial one. Restoring the cartilage in these joints would be an important advance in the treatment of osteoarthritis.

The scientists formed 3-D woven textile scaffolds from a biomaterial. The 22-mm scaffolds were shaped over a mold to mimic a hip joint surface and attached to a nylon mesh to maintain their shape. The mechanical properties of the scaffolds could be altered by varying the weave architecture.

Adult human fat-derived stem cells obtained from liposuction waste were seeded onto the outer surface of the porous scaffolds. The cells and scaffolds were maintained in tissue culture for 38 days. During this time, the cells grew to evenly cover the scaffolds. They produced a matrix made up of proteins, such as collagens, that are key components of joint cartilage. The matrix created a smooth, glistening appearance over the scaffolds.

The scientists next engineered a harmless virus to contain a gene with instructions to make the anti-inflammatory molecule IL-1 receptor antagonist (IL-1Ra). They attached this viral vector to the scaffolds and then added the stem cells, which attached and grew. When they added a chemical to the culture media to turn on the gene, the cells produced high levels of IL-1Ra. When inflammatory molecules were added to the cultures, the IL-1Ra prevented the production of a joint-damaging protein.

YOU MAY ALSO LIKE

Gut microbes from healthy infants block milk allergy development

New research suggests that the gut microbiome may help prevent the development of cow’s milk allergy.

Experimental treatment slows prion disease, extends life of mice

Scientists using an experimental treatment have slowed the progression of scrapie, a degenerative central nervous disease caused by prions, in laboratory mice and greatly extended the rodents’ lives.

Study Shows Chemotherapy Not Needed To Treat Many Breast Cancers

After a diagnosis of breast cancer, many women have surgery followed by chemotherapy and radiation. But a new study shows that if the cancer is caught early enough, women might be able to avoid the chemotherapy.

Acute kidney injury, chronic kidney disease each a risk of the other

Acute kidney injury and chronic kidney disease are closely intertwined, with each disease a risk factor for developing the other and sharing other risk factors in common, as well as sharing causes for the diseases to get worse, and outcomes, suggests a comprehensive analysis.

Moderate Carbohydrate Intake May be Best for Health

A new study has found that diets both low and high in carbohydrates were linked with an increase in mortality, while moderate consumers of carbohydrates had the lowest risk of mortality.

Structural Snapshots of Damaged DNA

Researchers revealed how nucleotides damaged by oxidative stress become inserted into DNA strands and block DNA repair mechanisms. The cell death triggered by this process is thought to play a role in many diseases.